Abstract: There is provided a biosensor for measuring a measuring target substance in a sample comprising an insulating substrate, an electrode pair provided on the insulating substrate, and a reagent that includes an oxidoreductase and an electron transfer substance and is provided at least on a working electrode of the electrode pair, wherein the working electrode is composed of one or more kinds of nickel alloys selected from the group consisting of a nickel-ruthenium alloy, a nickel-tungsten alloy, and a nickel-vanadium alloy.

Abstract: An information processing device includes a categorizing section configured to extract a material component image identified as a material component from plural images obtained by imaging a sample fluid containing a plurality of types of material components and flowing through a flow cell, and to categorize the extracted material component image by predetermined category, a count derivation section configured to derive a count of the material component per standard visual field, or derive a count per unit liquid volume of the material component contained in the sample fluid, for each of the categories based on the number of material component images categorized by the categorizing section, and a generation section configured to generate an all-component image in which the material component images are arranged according to the counts that have been derived by the count derivation section for each of the categories.

Abstract: A biosensor includes a plurality of electrodes including a working electrode, and a detection layer containing an enzyme for exchanging electrons with the working electrode, a crosslinking agent and an electrically conductive polymer and having a contact area with the working electrode defined by a predetermined area.

Abstract: A flow path for liquid chromatography, which analyzes hemoglobin within a blood sample, is subjected to a surface treatment with a liquid in which is dissolved a surface treating agent having a molecular weight of 200 or less and having two or more chemical structures in each of which a hydroxy group (—OH) and an oxo group (?O) are respectively bonded directly to one phosphor (P) atom.

Abstract: A measurement device includes an acquisition unit and a calculation unit. The acquisition unit acquires a first image obtained by image-capturing liquid containing tangible components flowing through a flow path and a second image image-captured simultaneously with the first image and having an image-capturing magnification higher than the first image. The calculation unit sorts, by using clipped images obtained by clipping the tangible components included in the first image and the second image, the tangible components into different types, and that calculates, by using a total number of the tangible components clipped out of the first image and included in a specified category as well as a ratio of a number of each of the tangible components of the different types clipped out of the second image and included in the specified category relative to a total number thereof, the number of the tangible components included in the specified category.

Abstract: A filter device includes a first filter, a first retaining member that has a hollow shape, the first filter being fitted inside the first retaining member, a second filter that has a smaller pore size than the first filter, a second retaining member that is disposed downstream of the first filter and that has a hollow shape, the second filter being fitted inside the second retaining member, and a spacer that has a hollow shape, that is disposed between the first retaining member and the second retaining member, that maintains a non-contact state between the first filter and the second filter, and that includes a first contact portion contacting the first filter.

Abstract: A method for treating a blood specimen with which capturing rates for both a small rare cell and a rare cell having a high deformability can be improved in the case where rare cells are contained in a blood specimen. The method for isolating or detecting a rare cell includes treating a blood specimen using a filter to isolate or detect a rare cell in the blood specimen.

Abstract: A determination method includes: using a microchip, including a capillary flow path and a sample reservoir connected to the capillary flow path at an upstream side, to fill the capillary flow path with a first solution for electrophoresis, and supply the sample reservoir with a second solution containing an analyte; applying a voltage between the sample reservoir supplied with the second solution and the inside of the capillary flow path filled with the first solution, to move a component contained in the second solution in the capillary flow path and separate the component in the capillary flow path; optically detecting a value related to a component difference between the first solution and the second solution, other than a value related to the analyte, for the separated component; and determining whether the optical detection is favorable or poor by comparing the optically detected value with a predetermined threshold value.

Abstract: A mutant cytochrome protein originated from a cytochrome protein having three heme-binding domains, which mutant cytochrome protein lacks the first heme-binding domain and the second heme-binding domain as counted from the N-terminus, is provided. The mutant cytochrome protein may lack a region(s) containing the first and second heme-binding domains.

Abstract: Provided is a method for separating particles, a separation apparatus, and a separation system.

Abstract: Provided is a method for measuring a glycoprotein using an enzymatic method, and the method includes simplified steps.

Abstract: A determination method includes: using a microchip, including a capillary flow path and a sample reservoir connected to the capillary flow path at an upstream side, to fill the capillary flow path with a first solution for electrophoresis, and supply the sample reservoir with a second solution containing an analyte; applying a voltage between the sample reservoir supplied with the second solution and the inside of the capillary flow path filled with the first solution, to move a component contained in the second solution in the capillary flow path and separate the component in the capillary flow path; optically detecting a value related to a component difference between the first solution and the second solution, other than a value related to the analyte, for the separated component; and determining whether the optical detection is favorable or poor by comparing the optically detected value with a predetermined threshold value.

Abstract: A mutant cytochrome protein originated from a cytochrome protein having three heme-binding domains, which mutant cytochrome protein lacks the first heme-binding domain and the second heme-binding domain as counted from the N-terminus, is provided. The mutant cytochrome protein may lack a region(s) containing the first and second heme-binding domains.

Abstract: By using a mutant glucose oxidase comprising an amino acid sequence in which a residue corresponding to isoleucine at position 489 or arginine at position 335 in the amino acid sequence of SEQ ID NO:1 is substituted with an amino acid residue having a reactive functional group in a side chain, and binding an electron acceptor to the mutant glucose oxidase through the amino acid residue having a reactive functional group, an electron acceptor-modified glucose oxidase is obtained.

Abstract: Detection and analysis of a tangible component in a sample are implemented at lower cost. Provided is an analysis apparatus including a flow cell which includes a flow path for a sample, a branch section configured to cause light having passed through the flow path to branch at least to a first optical path and a second optical path, a first imaging section and a second imaging section configured to capture images of the sample in the flow path by using the light in the first optical path and the light in the second optical path, and a controller configured to process the captured images. The first imaging section and the second imaging section capture images that have the same angle of view but have different characteristics.

Abstract: The present disclosure provides, in one aspect, a target substance detection method in which a trapping substance that indirectly binds to both an immobilization side (support side) and a detection side (reporter side), which is a method for detecting a target substance in a sample. The method includes a reaction step of reacting the sample, a support including a first binding portion, a reporter substance including a second binding portion, a first trapping substance that includes a first binding partner portion capable of binding to the first binding portion and that can bind to the target substance, and a second trapping substance that includes a second binding partner portion capable of binding to the second binding portion and that can bind to the target substance; and a detection step of detecting a signal from the reporter substance.

Abstract: There is provided a separation analysis method for analyzing a sample component s included in a sample liquid by introducing the sample liquid into a separation flow path filled with a flow path liquid, the method comprising: obtaining a correction factor representing a proportion of a time period from the first point in time when the sample liquid is introduced into the separation flow path, to the second point in time when an interface between the flow path liquid and the sample liquid reaches a predetermined position at the separation flow path, with respect to a time period from the first point in time to the third point in time when an optical characteristic value of the sample component is measured at the predetermined position, and correcting the measured optical characteristic value with the correction factor.

Abstract: A method of measuring stable A1c in a blood sample based on a time distribution of an optical measured value of hemoglobin at a flow path which separates hemoglobin in the blood sample on a basis of amounts of the charges of hemoglobin, the method comprising: a step of obtaining a correction factor, based on a peak area (A) of a fraction including HbA0 and either a peak area (G) of a first fraction including chemically-modified HbA0, or a peak area (D) of a second fraction including a component having a smaller amount of positive charge than HbA0 adjacent to a fraction identified as HbA0, in the time distribution; and a step of correcting, based on the correction factor a peak area of a fraction including stable A1c in the time distribution.